Evolution of Clinical and Molecular Responses to Bexarotene Treatment in Cutaneous T-Cell Lymphoma

Publisher： Karger

E-ISSN： 1421-9832|220|4|370-375

ISSN： 1018-8665

Source： Dermatology, Vol.220, Iss.4, 2010-05, pp. : 370-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene

By  

Case Reports in Dermatology, Vol. 4, Iss. 1, 2012-03 ,pp. : 56-60

Karger

Access to resources Recommend Favorite

Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox

By  

Case Reports in Dermatology, Vol. 3, Iss. 1, 2011-02 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Cutaneous T Cell Lymphoma: Update of Treatment

By  

Dermatology, Vol. 199, Iss. 2, 1999-10 ,pp. : 102-105

Karger

Access to resources Recommend Favorite

Hemolytic-Uremic Syndrome Induced by Pentostatin in a Patient with Cutaneous T-Cell Lymphoma

By  

Dermatology, Vol. 198, Iss. 2, 1999-04 ,pp. : 179-180

Karger

Access to resources Recommend Favorite

Imaging Cutaneous T-Cell Lymphoma with Optical Coherence Tomography

By  

Case Reports in Dermatology, Vol. 4, Iss. 2, 2012-07 ,pp. : 139-143

Karger

Access to resources Recommend Favorite